NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
Back to search
Official data from USPTO
CANIFERON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/23/2025
Trademark type
Word
Nice classes
5
Filing date
09/16/2021
Registration date
01/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2023
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BODRI,KRISTIN MARIE
Current location
Historical data usage
Holders and representatives
Holders
ILC Therapeutics Limited
Representatives
Brian M. Davis VLP Law Group LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsmedical and veterinary preparations for use in the treatment of skin diseasescancerpruritic disorders and inflammatory diseases; pharmaceuticalmedical and veterinary preparations for preventiondiagnosis and treatment of skin diseases; pharmaceuticalmedical and veterinary preparations for dermatitis; pharmaceuticalmedical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancerskin disorders and inflammatory diseases; pharmaceuticalmedical and veterinary preparations containing alpha interferon for the preventiondiagnosis and treatment of diseases and disorderscancerdermatitisskin diseases* pruritic conditionscoronavirus and allergies * and inflammatory diseases; pharmaceuticalmedical and veterinary preparations containing alpha interferon for the preventiondiagnosis and treatment of diseases and disorderscancerdermatitisskin diseases and inflammatory diseasesfor animals; pharmaceuticalmedical and veterinary drugs for use in the treatment of skin diseasescancerpruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseasescancerpruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseasescancerpruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseasescancerpruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use
Publications
History of USPTO decisions and trademark events.
29 publications found
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
05/13/2025
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
05/01/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/24/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/24/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/05/2023
FIMP
FINAL DISPOSITION PROCESSED
05/05/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2023
DOCK
ASSIGNED TO EXAMINER
12/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2022
PUBO
PUBLISHED FOR OPPOSITION
11/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2022
RFNT
REFUSAL PROCESSED BY IB
07/19/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/24/2022
RFRR
REFUSAL PROCESSED BY MPU
06/24/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/22/2022
CNRT
NON-FINAL ACTION WRITTEN
06/21/2022
DOCK
ASSIGNED TO EXAMINER
06/21/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/14/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/09/2021
Continuous trademark protection
Get notified about every new filing that threatens CANIFERON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.